References
- MacLean E, Kohli M, Weber SF, Suresh A, Schumacher SG, Denkinger CM, et al. Advances in molecular diagnosis of tuberculosis. J Clin Microbiol 2020;58:e01582-19.
- Centers for Disease Control and Prevention. Nucleic acid amplification tests for tuberculosis. MMWR Morb Mortal Wkly Rep 1996;45:950-2.
- Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-15. https://doi.org/10.1056/NEJMoa0907847
- Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014;2014:CD009593.
- Li S, Liu B, Peng M, Chen M, Yin W, Tang H, et al. Diagnostic accuracy of Xpert MTB/RIF for tuberculosis detection in different regions with different endemic burden: a systematic review and meta-analysis. PLoS One 2017;12:e0180725. https://doi.org/10.1371/journal.pone.0180725
- Agizew T, Boyd R, Auld AF, Payton L, Pals SL, Lekone P, et al. Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear: a systematic review and meta-analysis. Int J Tuberc Lung Dis 2019;23:82-92. https://doi.org/10.5588/ijtld.18.0203
- Di Tanna GL, Khaki AR, Theron G, McCarthy K, Cox H, Mupfumi L, et al. Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis. Lancet Glob Health 2019;7:e191-9. https://doi.org/10.1016/S2214-109X(18)30458-3
- Cazabon D, Suresh A, Oghor C, Qin ZZ, Kik SV, Denkinger CM, et al. Implementation of Xpert MTB/RIF in 22 high tuberculosis burden countries: are we making progress? Eur Respir J 2017;50:1700918. https://doi.org/10.1183/13993003.00918-2017
- World Health Organization. Molecular assays intended as initial tests for the diagnosis of pulmonary and extrapulmonary TB and rifampicin resistance: rapid communication. Policy update [Internet]. Geneva: World Health Organization; 2020 [cited 2021 Jun 10]. Available from: https://www.who.int/publications/i/item/9789240000339.
- Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korean Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 2nd ed. [Internet]. Seoul and Cheongju: Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention; 2014 [cited 2021 Jun 10]. Available from: https://www.lungkorea.org/bbs/index.html?code=guide&category=&gubun=&page=4&number=3480&mode=view&keyfield=&key=.
- Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korean Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. 3rd ed. [Internet]. Seoul and Cheongju: Joint Committee for the Revision of Korean Guidelines for Tuberculosis, Korea Centers for Disease Control and Prevention; 2017 [cited 2021 Jun 10]. Available from: https://www.lungkorea.org/bbs/index.html?code=guide&category=&gubun=&page=2&number=7563&mode=view&keyfield=&key=.
- Greco S, Girardi E, Navarra A, Saltini C. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 2006;61:783-90. https://doi.org/10.1136/thx.2005.054908
- Park KS, Kim JY, Lee JW, Hwang YY, Jeon K, Koh WJ, et al. Comparison of the Xpert MTB/RIF and Cobas TaqMan MTB assays for detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol 2013;51:3225-7. https://doi.org/10.1128/JCM.01335-13
- Ko Y, Lee HK, Lee YS, Kim MY, Shin JH, Shim EJ, et al. Accuracy of Xpert((R)) MTB/RIF assay compared with AdvanSure TB/NTM real-time PCR using bronchoscopy specimens. Int J Tuberc Lung Dis 2016;20:115-20. https://doi.org/10.5588/ijtld.15.0227
- Kim MJ, Nam YS, Cho SY, Park TS, Lee HJ. Comparison of the Xpert MTB/RIF assay and real-time PCR for the detection of Mycobacterium tuberculosis. Ann Clin Lab Sci 2015;45:327-32.
- Teo J, Jureen R, Chiang D, Chan D, Lin R. Comparison of two nucleic acid amplification assays, the Xpert MTB/RIF assay and the amplified Mycobacterium Tuberculosis Direct assay, for detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 2011;49:3659-62. https://doi.org/10.1128/JCM.00211-11
- Jo YS, Park JH, Lee JK, Heo EY, Chung HS, Kim DK. Discordance between MTB/RIF and real-time tuberculosisspecific polymerase chain reaction assay in bronchial washing specimen and its clinical implications. PLoS One 2016;11:e0164923. https://doi.org/10.1371/journal.pone.0164923
- Miller MB, Popowitch EB, Backlund MG, Ager EP. Performance of Xpert MTB/RIF RUO assay and IS6110 real-time PCR for Mycobacterium tuberculosis detection in clinical samples. J Clin Microbiol 2011;49:3458-62. https://doi.org/10.1128/JCM.05212-11
- Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, et al. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med 2011;8:e1001061. https://doi.org/10.1371/journal.pmed.1001061
- Kim CH, Woo H, Hyun IG, Kim C, Choi JH, Jang SH, et al. A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying Mycobacterium tuberculosis during routine clinical practice. J Thorac Dis 2014;6:625-31.
- Zifodya JS, Kreniske JS, Schiller I, Kohli M, Dendukuri N, Schumacher SG, et al. Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis. Cochrane Database Syst Rev 2021;2:CD009593.
- Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, et al. Evaluation of a rapid molecular drug-susceptibility test for tuberculosis. N Engl J Med 2017;377:1043-54. https://doi.org/10.1056/NEJMoa1614915
- Jo KW, Lee S, Kang MR, Sung H, Kim MN, Shim TS. Frequency and type of disputed rpoB mutations in Mycobacterium tuberculosis isolates from South Korea. Tuberc Respir Dis 2017;80:270-6. https://doi.org/10.4046/trd.2017.80.3.270
- Yadav RN, Kumar Singh B, Sharma R, Chaubey J, Sinha S, Jorwal P. Comparative performance of Line Probe Assay (Version 2) and Xpert MTB/RIF Assay for early diagnosis of rifampicin-resistant pulmonary tuberculosis. Tuberc Respir Dis 2021;84:237-44. https://doi.org/10.4046/trd.2020.0171
- Zong K, Luo C, Zhou H, Jiang Y, Li S. Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis. BMC Microbiol 2019;19:177. https://doi.org/10.1186/s12866-019-1516-5
- Shankar SU, Kumar AM, Venkateshmurthy NS, Nair D, Kingsbury R, R P, et al. Implementation of the new integrated algorithm for diagnosis of drug-resistant tuberculosis in Karnataka State, India: How well are we doing? PLoS One 2021;16:e0244785. https://doi.org/10.1371/journal.pone.0244785
- Chiang TY, Fan SY, Jou R. Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting. PLoS One 2018;13:e0200755. https://doi.org/10.1371/journal.pone.0200755